Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYVE.L Regulatory News (HYVE)

  • There is currently no data for HYVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - HYVE GROUP PLC Amend

22 Mar 2023 14:36

RNS Number : 9046T
Barclays PLC
22 March 2023
 

FORM 8.3 Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short positions disclosed, if different from 1(a):

 

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

HYVE GROUP PLC

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e)

Date position held/dealing undertaken:

20 Mar 2023

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

NO

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing(if any)

Class of relevant security:

10p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

8,989,047

3.08%

261,675

0.09%

(2) Cash-settled derivatives:

136,978

0.05%

8,816,072

3.02%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 

0

0.00%

0

0.00%

TOTAL: 

9,126,025

3.13%

9,077,747

3.11%

(b)

Rights to subscribe for new securities (including directors and other executive options)

Class of relevant security in relation to which subscription right exists

Details, including nature of the rights concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

10p ordinary

Purchase

192

1.1140 GBP

10p ordinary

Purchase

18,097

1.1080 GBP

10p ordinary

Purchase

31,284

1.1082 GBP

10p ordinary

Purchase

118,405

1.1055 GBP

10p ordinary

Sale

52

1.1120 GBP

10p ordinary

Sale

353

1.1100 GBP

10p ordinary

Sale

8,010

1.1089 GBP

10p ordinary

Sale

33,472

1.1080 GBP

(b)

Cash-settled derivative transactions

Class of relevant security

Product description

Nature of dealing

Number of reference securities

Price per unit

10p ordinary

SWAP

Long

405

1.1101 GBP

10p ordinary

SWAP

Short

192

1.1141 GBP

10p ordinary

CFD

Short

7,899

1.1079 GBP

10p ordinary

CFD

Short

118,405

1.1055 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

Option money paid/ received per unit

(ii)

Exercising

 

Class of relevant security

Product description

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of Dealings

Details

Price per unit (if applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights of future acquisition or disposal of any relevant securities to which any derivative is referenced:

NONE

(c)

Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

22 Mar 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSEIFLEEDSEDD
Date   Source Headline
9th Mar 20222:09 pmRNSHolding(s) in Company
7th Mar 20224:27 pmRNSHolding(s) in Company
3rd Mar 20229:55 amRNSHolding(s) in Company
3rd Mar 20227:00 amRNSDirector/PDMR Shareholding
2nd Mar 202212:23 pmRNSDirector/PDMR Shareholding
1st Mar 20221:41 pmRNSHolding(s) in Company
28th Feb 20224:21 pmRNSHolding(s) in Company
28th Feb 20221:24 pmRNSResponse to the Russia/Ukraine conflict
28th Feb 202211:06 amRNSHolding(s) in Company
11th Feb 202212:50 pmRNSHolding(s) in Company
3rd Feb 20229:50 amRNSAnnouncement of Results of Annual General Meeting
3rd Feb 20227:00 amRNSBoard Changes
3rd Feb 20227:00 amRNSTrading Update
26th Jan 20222:50 pmRNSHolding(s) in Company
11th Jan 20229:33 amRNSHolding(s) in Company
5th Jan 202211:09 amRNSPublication of Annual Report and Notice of AGM
20th Dec 20213:17 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFY21 Preliminary Results
1st Dec 20217:00 amRNSVoting Rights and Capital
24th Nov 20215:17 pmRNSHolding(s) in Company
23rd Nov 20214:16 pmRNSHolding(s) in Company
23rd Nov 20211:59 pmRNSHolding(s) in Company
18th Nov 20211:54 pmRNSDirector/PDMR Shareholding
18th Nov 20219:41 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSAcquisition of 121 Group & Agreement with Lenders
18th Nov 20217:00 amRNSProposed placing and direct subscription
11th Nov 20215:48 pmRNSCorrection - Director/PDMR Shareholding
26th Oct 20212:54 pmRNSDirector/PDMR Shareholding
25th Oct 202111:26 amRNSAnnouncement of Results of General Meeting
13th Oct 20211:16 pmRNSDirector Declaration
8th Oct 20219:28 amRNSNotice of General Meeting
7th Oct 20217:00 amRNSPre-close trading update
1st Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 20213:26 pmRNSHolding(s) in Company
20th Jul 20215:13 pmRNSHolding(s) in Company
13th Jul 20214:34 pmRNSHolding(s) in Company
8th Jul 20217:00 amRNSTrading Update
24th Jun 202110:38 amRNSHolding(s) in Company
23rd Jun 20219:13 amRNSHolding(s) in Company
1st Jun 20217:00 amRNSResponse to recent press speculation
28th May 202111:48 amRNSHolding(s) in Company
26th May 202111:09 amRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
11th May 20212:16 pmRNSHolding(s) in Company
26th Apr 202112:44 pmRNSHolding(s) in Company
23rd Apr 20214:08 pmRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading Update
1st Apr 202110:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 202111:50 amRNSHolding(s) in Company
22nd Feb 20212:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.